Patent details
300543
Product Name:
Vandetanib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300543
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1244647
Status:
SPC in force
Application number:
300543
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Paediatric Extension
SPC Extension Filing Date:
03/05/2017
SPC Extension Agent/Owner Name:
Genzyme Corporation
, ir. F.A. Geurts c.s.
SPC Extension Status:
Application Withdrawn
SPC Extension Grant Date:
SPC Extension Request Refusal Date:
SPC Extension Revocation Date:
Marketing Authorization
Marketing Authorization Number:
EU/1/11/749/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
17/02/2012
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
08/08/2012
First Marketing Authorization date:
17/02/2012
Grant date:
27/08/2012
Activation date:
01/11/2020
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
08/08/2012
SPC/SPC Extension Expiration Date:
31/10/2025
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
07/03/2016
Name:
Genzyme Corporation
Address:
500 Kendall Street, 02142, Cambridge, Massachusetts, United States of America (US)
Historical Applicant/holder
From:
08/08/2012
To:
07/03/2016
Name:
AstraZeneca AB
Address:
Gobal Intellectual Property, S-151 85, Södertälje, Sweden (SE)
Agent
Name:
ir. F.A. Geurts c.s.
From:
08/08/2012
Address:
Octrooibureau Vriesendorp & Gaade B.V.
Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
45/20
Publication date:
04/11/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
19/17
Publication date:
10/05/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
MED
Journal edition number:
40/16
Publication date:
05/10/2016
Description:
Other communications
4
Bulletin Heading:
CO
Journal edition number:
27/16
Publication date:
06/07/2016
Description:
Changes in the Netherlands Patent Register
5
Bulletin Heading:
SPC
Journal edition number:
2012/36
Publication date:
05/09/2012
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
6
Bulletin Heading:
SPC
Journal edition number:
2012/33
Publication date:
15/08/2012
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC201601250A
Date Registered:
07/03/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Correction of Inscription
Change Kind/ Decision Type:
Based on clerical error
Deed Number:
RC201601251A
Date Registered:
07/03/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
De nieuwe houder na RFC201601250 moet zijn Genzyme Corporation.
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
31/10/2024
Annual Fee Number:
25
Annual Fee Amount:
2400 Euro
Last Annual Payment Date:
17/10/2023
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
2200 Euro
Payer:
Arnold & Siedsma BV
Filing date
Document type
Document Description
Number of pages
File Type
03/08/2017
Outgoing Correspondence
Letter confirmation withdrawal
1
PDF
/3/4/5/0/0/0400300543/docs/300543_6_outgoingcorrespondence20170804104920762.pdf
30/05/2017
Outgoing Correspondence
Letter to applicant
2
PDF
/3/4/5/0/0/0400300543/docs/300543_1_outgoingcorrespondence20170601103054792.pdf
26/05/2017
SPC Documents
Withdrawal SPC
1
PDF
/3/4/5/0/0/0400300543/docs/300543_10_supplprotectioncertificate20200929014805797.pdf
10/05/2017
Outgoing Correspondence
Confirmation receipt request for extension
1
PDF
/3/4/5/0/0/0400300543/docs/300543_13_135996l505.pdf
03/05/2017
SPC Documents
Certificate SPC
1
PDF
/3/4/5/0/0/0400300543/docs/300543_0_supplprotectioncertificate20170510120702111.pdf
03/05/2017
SPC Documents
Annex SPC
19
PDF
/3/4/5/0/0/0400300543/docs/300543_8_supplprotectioncertificate20200929022317326.pdf
03/05/2017
SPC Documents
Annex SPC
10
PDF
/3/4/5/0/0/0400300543/docs/300543_12_supplprotectioncertificate20200929022528373.pdf
03/05/2017
Application Form
First filed application form
3
PDF
/3/4/5/0/0/0400300543/docs/300543_14_applicationform20170510120701896.pdf
27/08/2012
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/4/5/0/0/0400300543/docs/300543_4_outgoingcorrespondence20120827.pdf
27/08/2012
SPC Documents
Certificate SPC
1
PDF
/3/4/5/0/0/0400300543/docs/300543_9_supplprotectioncertificate20200929021747097.pdf
08/08/2012
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/4/5/0/0/0400300543/docs/300543_2_outgoingcorrespondence20120808.pdf
08/08/2012
Application Form
First filed application form
3
PDF
/3/4/5/0/0/0400300543/docs/300543_3_applicationform20120808.pdf
08/08/2012
SPC Documents
Marketing Authorization SPC
4
PDF
/3/4/5/0/0/0400300543/docs/300543_5_supplprotectioncertificate20200929021410506.pdf
08/08/2012
SPC Documents
Summary of the characteristics of the product
33
PDF
/3/4/5/0/0/0400300543/docs/300543_7_supplprotectioncertificate20200929020723860.pdf
08/08/2012
SPC Documents
Annex SPC
4
PDF
/3/4/5/0/0/0400300543/docs/300543_11_supplprotectioncertificate20200929020835974.pdf